A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults with Multifocal Motor Neuropathy

PHASE2CompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

March 31, 2022

Primary Completion Date

June 4, 2024

Study Completion Date

June 4, 2024

Conditions
Multifocal Motor Neuropathy
Interventions
BIOLOGICAL

ARGX-117

Intravenous administration of ARGX-117

OTHER

Placebo

Intravenous administration of placebo

Trial Locations (40)

1090

Medizinische Universitat Wien Universitatsklienik fur Neurologie, Vienna

9000

AZ Sint-Lucas, Ghent

19104

Perelman Center for Advanced Medicine-University of Penssylvania, Philadelphia

20037

George Washington Medical Faculty Associates, Washington D.C.

20089

Instituto Clinico Humanitas (IRCCS), Rozzano

20132

IRCCS Ospedale San Raffaele, Milan

26506

West Virginia University Medicine, Morgantown

27514

University of North Carolina at Chapel Hill, Chapel Hill

30625

Medizinische Hochschule Hannover Klinik Fur Neurologie, Hanover

32751

HonorHealth Research Institute-Neuroscience Research, Maitland

33076

CHU de Bordeaux-Hopital Pellegrin, Bordeaux

33612

University of South Florida Carol and Frank Morsani Center for Advanced Healthcare, Tampa

37075

Universitatsmedzin Gottingen, Klinik fur Neurologie, Göttingen

44195

Cleveland Clinic, Cleveland

44791

Katholisches Klinikum Bochum, Bochum

45147

Universitatsklinikum Essen, Essen

46026

Hospital Universitari I Politecnic La Fe de Valencia-Servicio Neurologia, Valencia

48419

Universitatsklinikum Munster, Münster

55414

University of Minnesota Delware Clinic Research Unit, Minneapolis

56126

Azienda Ospedaliero Univeritaria Pisana-UOS Neurologia, Pisa

59037

CHRU de Lille-Hopital Roger Salengro, Lille

60026

NorthShore University HealthSystem, Glenview

66160

University of Kansas Medical Center, Kansas City

75651

Hopital Pitie Salpetriere, Paris

78756

Austin Neuromuscular Center, Austin

85251

HonorHealth Research Institute-Neuroscience Research, Scottsdate

94109

California Pacific Medical Center-Forbes Norris MDA/ALS Research Center, San Francisco

H4A 3TA

Genge Partners Montreal, Québec

M5G 2C4

Toronto General Hospital, Toronto

06001

CHU de Nice-Hopital Pasteur 2, Nice

00189

Azienda Ospedaliera Sant'Andrea-UOS Malattie Neuromuscolari, Rome

1105 AZ

Amsterdam UMC location AMC, Dep of Neurology, Amsterdam

3584 CX

University Medical Centre Utrecht, Utrecht

31-426

Michalscy I Partnerzy Lekarze Spolka Partnerska, Krakow

02-097

Uniwersyteckie centrum kliniczne Warszawskiego, Warsaw

08035

Hospital Universitario Vall d'Herbon, Barcelona

08041

Hospital de la Santa Creu I Santa Pau -Sevicio Neurologia, Barcelona

G51 4TF

Queen Elisabeth University Hospital, Glasgow

ZC1N 3BG

University College London Hospital, London

OX3 9DU

Oxford University Hospitals NHS Trust-Jonh Radcliffe Hospital, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

argenx

INDUSTRY

NCT05225675 - A Clinical Trial to Investigate the Safety and Tolerability, Efficacy, Pharmacokinetics, Pharmacodynamics and Immunogenicity of 2 Dose Regimens of ARGX-117 in Adults with Multifocal Motor Neuropathy | Biotech Hunter | Biotech Hunter